Windlas Biotech

WINDLAS03 May 2024

Pharmaceuticals

₹

-3.80 (-0.69%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Windlas Biotech

Windlas Biotech

Pharmaceuticals

WINDLAS03 May 2024

₹

-3.80 (-0.69%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-May-2023	D	Outcome of Board Meeting Recommended a Dividend of Rs 4.00/- per Equity Share of face value of Rs. 5/- each. The said dividend, if declared by the Members of the Company at the ensuing Annual General Meeting (AGM), will be credited/despatched within three weeks of the conclusion of said AGM.	05-Sep-2023
12-May-2022	D	Windlas Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 12, 2022, inter alia, has recommended a Dividend of Rs. 3.50/- per Equity Share of face value of Rs. 5/- each (@70%). The said dividend, if declared by the Members of the Company at the ensuing Annual General Meeting (AGM), will be credited/despatched within three weeks of the conclusion of said AGM.	09-Sep-2022
30-Jan-2024	BC	Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve A meeting of the Board of Directors of the	08-Feb-2024
30-Oct-2023	BC	Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve To inter alia consider and approve the un-a	08-Nov-2023
16-Aug-2023	BC	Intimation of Record date and book closure for the purpose of AGM Intimation of cut-off and eVoting (As Per BSE Announcement dated on 18.08.2023) Proceedings of the 22nd Annual General Meeti	12-Sep-2023
13-Sep-2023	BC	Voting Results of 22nd AGM along with the scrutiniser''s report dated September 12, 2023, enclosed.	12-Sep-2023
17-Aug-2023	BC	Rs.4.0000 per share(80%)Final Dividend & A.G.M	06-Sep-2023

No Rights has been declared by WINDLAS

Book Closure

Record Date	Split Date	Purpose
08-Feb-2024	-	Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve A meeting of the Board of Directors of the
08-Nov-2023	-	Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve To inter alia consider and approve the un-a
12-Sep-2023	-	Intimation of Record date and book closure for the purpose of AGM Intimation of cut-off and eVoting (As Per BSE Announcement dated on 18.08.2023) Proceedings of the 22nd Annual General Meeti
12-Sep-2023	-	Voting Results of 22nd AGM along with the scrutiniser''s report dated September 12, 2023, enclosed.
06-Sep-2023	01 Jan'1900	Rs.4.0000 per share(80%)Final Dividend & A.G.M

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Windlas Biotech Ltd ₹548.40(-3.80/-0.69%)	548.40	-3.80	1,140.59	117.23	21.67	2.74
Astrazeneca Pharma India Ltd ₹5,424.45(+90.60/1.70%)	5,424.45	+90.60	13,561.13	71.45	85.02	20.71
Bliss GVS Pharma Ltd ₹119.10(-10.10/-7.82%)	119.10	-10.10	1,246.87	56.07	18.27	1.28
Cipla Ltd ₹1,424.75(+5.20/0.37%)	1,424.75	+5.20	115,033.60	54.70	34.98	4.44
Amrutanjan Health Care Ltd ₹775.50(-11.10/-1.41%)	775.50	-11.10	2,242.02	27.78	50.95	8.56
Abbott India Ltd ₹26,144.45(-459.90/-1.73%)	26,144.45	-459.90	55,556.96	15.92	48.50	17.87

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	162.21	152.67	144.79	140.71	119.70	132.73
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	162.21	152.67	144.79	140.71	119.70	132.73
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	3.16	3.24	2.62	2.33	2.16	2.61
Total Income	165.38	155.91	147.41	143.05	121.87	135.34
Total Expenditure	141.88	133.99	127.64	124.27	105.76	116.67
PBIDT	23.50	21.93	19.77	18.78	16.11	18.67
Interest	0.31	0.29	0.24	0.16	0.16	0.12
PBDT	23.20	21.64	19.53	18.61	15.95	18.56
Depreciation	3.39	3.33	3.19	3.57	3.14	2.91
Tax	4.47	4.37	3.98	4.21	2.77	3.73
Deferred Tax	0.24	-0.09	0.29	-0.61	0.87	-0.29
Reported Profit After Tax	15.10	14.03	12.07	11.45	9.19	12.21
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	15.10	14.03	12.07	11.45	9.19	12.21

EPS (Unit Curr.)	7.26	6.75	5.79	5.37	4.24	5.60
EPS (Adj) (Unit Curr.)	7.26	6.75	5.79	5.37	4.24	5.60
Calculated EPS (Unit Curr.)	7.26	6.75	5.80	5.47	4.29	5.60
Calculated EPS (Adj) (Unit Curr.)	7.26	6.75	5.80	5.47	4.29	5.60
Calculated EPS (Ann.) (Unit Curr.)	29.04	26.99	23.21	21.88	17.14	22.41
Calculated EPS (Adj) (Ann.) (Unit Curr.)	29.04	26.99	23.21	21.88	17.14	22.41
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.40	10.40	10.40	10.46	10.72	10.90
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	5.00	5.00	5.00	5.00	5.00	5.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	14.49	14.36	13.65	13.35	13.46	14.07
PBDTM(%)	14.30	14.17	13.49	13.23	13.32	13.98
PATM(%)	9.31	9.19	8.34	8.14	7.68	9.20

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	162.21	152.67	144.79	140.71	119.70	132.73
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	162.21	152.67	144.79	140.71	119.70	132.73
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	3.16	3.24	2.62	2.33	2.16	2.61
Total Income	165.38	155.91	147.41	143.05	121.87	135.34
Total Expenditure	141.88	133.99	127.64	124.27	105.76	116.69
PBIDT	23.50	21.93	19.77	18.77	16.11	18.66
Interest	0.31	0.29	0.24	0.17	0.16	0.12
PBDT	23.20	21.64	19.53	18.61	15.95	18.54
Depreciation	3.39	3.33	3.19	3.57	3.14	2.91
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	4.47	4.37	3.98	4.21	2.77	3.73
Deferred Tax	0.24	-0.09	0.29	-0.61	0.87	-0.29
Reported Profit After Tax	15.10	14.03	12.07	11.44	9.19	12.19
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	15.10	14.03	12.07	11.44	9.19	12.19

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	15.10	14.03	12.07	11.44	9.19	12.19

EPS (Unit Curr.)	7.26	6.75	5.79	5.37	4.23	5.59
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.40	10.40	10.40	10.46	10.72	10.90

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	14.49	14.36	13.65	13.34	13.46	14.06
PBDTM(%)	14.30	14.17	13.49	13.23	13.32	13.97
PATM(%)	9.31	9.19	8.34	8.13	7.68	9.18

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.46	10.90	6.41	6.41	6.41	8.53
Reserves Total	392.20	384.23	192.58	210.07	187.61	158.20
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	402.66	395.13	198.99	216.48	194.02	166.73
Secured Loans	0.44	6.12	30.24	22.16	22.89	30.01
Unsecured Loans	4.55	0.52	2.11	5.27	7.02	9.59
Total Debt	4.99	6.64	32.35	27.43	29.91	39.60
Total Liabilities	407.65	401.77	231.34	243.91	223.93	206.33
APPLICATION OF FUNDS :
Gross Block	194.30	163.87	157.00	140.72	125.74	114.06
Less : Accumulated Depreciation	84.89	72.69	61.06	72.29	63.81	55.84
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	109.41	91.18	95.94	68.43	61.93	58.22
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	14.78	8.01	0.04	0.00	4.58	10.51
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	106.55	64.86	23.18	120.98	120.98	123.47
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	74.74	58.71	41.46	49.32	19.03	26.51
Sundry Debtors	116.86	110.77	79.41	64.56	62.26	59.47
Cash and Bank	25.45	113.81	30.96	18.38	13.20	5.61
Loans and Advances	29.97	33.52	19.18	14.11	5.60	7.27
Total Current Assets	247.03	316.81	171.01	146.36	100.08	98.85
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	117.97	87.13	62.14	98.29	67.44	86.70
Provisions	1.04	0.33	0.28	0.41	4.58	4.92
Total Current Liabilities	119.01	87.46	62.42	98.70	72.02	91.62
Net Current Assets	128.01	229.35	108.58	47.67	28.06	7.23
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	3.65	3.07	0.00	1.97	1.84	1.65
Deferred Tax Liability	1.63	1.04	0.68	0.00	0.00	0.00
Net Deferred Tax	2.02	2.03	-0.68	1.97	1.84	1.65
Total Assets	360.77	395.44	227.06	239.05	217.39	201.08
Contingent Liabilities	0.00	2.53	0.00	0.00	0.00	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.46	10.90	6.41	6.41	6.41	5.59
Reserves Total	391.81	383.88	192.71	203.25	187.17	116.51
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	2.94
Total Shareholders Funds	402.27	394.78	199.12	209.66	193.58	125.04
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	0.44	6.12	30.24	27.43	29.91	55.11
Unsecured Loans	4.55	0.52	2.11	1.50	1.93	2.32
Total Debt	4.99	6.64	32.35	28.93	31.84	57.43
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	2.34	1.80	1.55	1.29	1.06	1.69
Total Liabilities	409.60	403.22	233.02	239.88	226.48	184.16
APPLICATION OF FUNDS :
Gross Block	194.30	163.87	157.00	79.35	84.85	103.81
Less: Accumulated Depreciation	84.89	72.69	61.06	9.09	20.59	17.32
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	109.41	91.18	95.94	70.26	64.26	86.49
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	14.78	8.01	0.04	0.00	4.58	52.56
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	106.51	64.82	23.14	116.28	122.35	22.57
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	74.74	58.71	41.46	49.32	19.03	35.05
Sundry Debtors	116.86	110.77	79.41	63.94	61.74	66.59
Cash and Bank	25.45	113.82	31.11	18.38	13.20	7.66
Loans and Advances	29.97	33.52	19.19	14.11	5.61	12.26
Total Current Assets	247.03	316.83	171.17	145.75	99.56	121.57
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	118.34	87.46	62.13	98.19	67.43	100.47
Provisions	1.04	0.33	0.28	0.41	4.26	5.26
Total Current Liabilities	119.37	87.79	62.42	98.60	71.69	105.72
Net Current Assets	127.65	229.04	108.76	47.15	27.88	15.85
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	3.65	3.07	1.32	3.08	2.89	2.81
Deferred Tax Liability	1.63	1.04	2.01	2.42	2.39	2.07
Net Deferred Tax	2.02	2.03	-0.69	0.66	0.50	0.74
Other Assets	49.23	8.13	5.84	5.53	6.92	5.96
Total Assets
Contingent Liabilities	0.00	2.53	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.55	15.78	23.74	12.86	5.53
Net Cash from Operating Activities	60.98	9.00	11.45	20.87	22.08
Net Cash Used In Investing Activities	-14.11	-154.31	-20.19	-9.16	-6.59
Net Cash Used In Financing Activities	-43.74	130.09	0.78	-6.48	-8.17
Net Inc./Dec In Cash And Cash Equivalents	3.13	-15.22	-7.97	5.22	7.32
Cash And Cash Equivalents At End Of The Year	3.69	0.55	15.78	18.08	12.86

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

62.82%

FII Shareholding

1.18%

DII Shareholding

11.82%

Public Shareholding

24.19%

**Promoter pledged shareholding 62.82%

About Windlas Biotech Ltd

Windlas Biotech Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 1140.59 crores. It has reported a sales of Rs. 162.21 crores and a net profit of Rs. 15.1 crores for the quarter ended December 2018. The company management includes Vivek Dhariwal, Vivek Dhariwal,Ashok Kumar Windlass,Hitesh Windlass,Manoj Kumar Windlass,Pawan Kumar Sharma,Prachi Jain Windlass,Srinivasan Venkataraman,Gaurav Gulati,Ananta Narayan Panda (Windlas Biotech Ltd) among others.

Chairman

Vivek Dhariwal

Registered office

40/1 Mohabewala Industrial,Area,Dehradun,Uttarakhand,248110

FAX :

Background

Incorporation Year2001

Face Value₹5

Market Lot1

How to buy Windlas Biotech shares on nse?

To buy Windlas Biotech shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Windlas Biotech share price today?

The Windlas Biotech shares price on nse is Rs.548.4 today.

What is the market cap of Windlas Biotech shares on BSE ?

The company has a market capitalization of Rs.1140.59Cr

What is the PE & PB ratio of Windlas Biotech shares ?

PE is 21.67 and PB is 2.74

What is the 52 Week High and Low of Windlas Biotech shares?

Windlas Biotech stock price high: Rs.590 Windlas Biotech stock price low: Rs.251.15